3 results
Approved WMOWill not start
The primary objective is to investigate the efficacy, safety and tolerability of RV 001 (a fully human anti-IGF-1R antibody) administered q3W for 6 months, in comparison to placebo, in the treatment of patients suffering from active TED.Secondary…
Approved WMOWill not start
Primary: To evaluate the safety of the study device in patients presenting with severe aortic stenosis (AS) considered to be high risk for surgery.Secondary: To evaluate adverse events and study device performance.
Approved WMOPending
To identify the role of dopamine transmission in the GC layer on motor learning in healthy individuals during cerebellar specific motor adaptation tasks.